Welcome to AstraZeneca
Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person

I am a payer or formulary decision-maker

I am neither (take me to AstraZeneca.com)

Chronic Obstructive Pulmonary Disease

Publications & Congresses

This section provides links to AstraZeneca publications that present data and real-world evidence from studies on COPD. It also includes access to recent congress content via the AstraZeneca Congress Library. The Congress Library includes links to posters and abstracts from AstraZeneca sponsored studies that were presented at medical congresses.

Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review

Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation

CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care

CONQUEST: A Quality Improvement Program for Defining and Optimizing Standards of Care for Modifiable High-Risk COPD Patients

Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study

US-87032 Last Updated 6/24

Welcome to AstraZeneca Medical Information

Welcome to AstraZeneca
Medical Information